Physician profile
Roy Baskin
NPI 1871113183
$2,839.78
in general payments reported to CMS, 2019-2025
23 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $460 · 2021: $276 · 2022: $278 · 2023: $1,280 · 2024: $360 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $825.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,007.27 | 2023-2025 | Davinci Xi |
| Ethicon US, LLC | $363.59 | 2020-2025 | Echelon; Endopath, Echelon Flex, Enseal X1 |
| Medical Device Business Services, INC. | $305.00 | 2020 | |
| Abbvie INC. | $167.74 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps, Alloderm |
| Stryker Corporation | $150.78 | 2020-2023 | Spy-Phi System |
| Allergan, INC. | $148.84 | 2021-2022 | |
| Urgo Medical North America, LLC | $94.29 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Csl Behring | $82.12 | 2020-2021 | |
| Tela Bio, INC. | $68.01 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kci USA, INC. | $67.70 | 2020-2022 | |
| Medtronic, INC. | $56.02 | 2023-2025 | Signia |
| Astrazeneca Pharmaceuticals Lp | $40.77 | 2022-2024 | |
| Lemaitre Vascular, INC. | $40.26 | 2023 | Xenosure Biologic Patch |
| Solventum Corporation | $39.96 | 2024-2025 | Prevena, Abthera Advance, V.A.C. Veraflo |
| Smith+Nephew, INC. | $33.59 | 2025 | Pico, Stravix |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $33.19 | 2021-2022 | |
| Pfizer INC. | $28.18 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $23.52 | 2023 | Camzyos |
| Acera Surgical, INC. | $21.99 | 2024 | Restrata Wound Matrix |
| Avanos Medical | $21.43 | 2022 | |
| Cardiovascular Systems INC. | $16.95 | 2021 | |
| Kerecis Limited | $14.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| W. L. Gore & Associates, INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Baskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.